The SARS-CoV-2 B.1.1.7 variant and increased clinical severity—the jury is out

COG-UK Consortium; PACIFIC-19 Consortium; Samuel Robson; Anoop Chauhan

doi:10.1016/S1473-3099(21)00356-X

The SARS-CoV-2 B.1.1.7 variant and increased clinical severity—the jury is out

COG-UK Consortium, PACIFIC-19 Consortium, Samuel Robson, Anoop Chauhan

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English
Pages (from-to)	1213-1214
Number of pages	2
Journal	The Lancet Infectious Diseases
Volume	21
Issue number	9
DOIs	https://doi.org/10.1016/S1473-3099(21)00356-X
Publication status	Published - Sept 2021

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/S1473-3099(21)00356-X

Dataset: GISAID EpiCov SARS-CoV-2 Whole Genome Sequencing Database
Robson, S. (Creator), GISAID, 2020
https://www.epicov.org/epi3/frontend#3bd481
Dataset
COVID-19 Genomics UK (COG-UK) consortium
Robson, S. (Creator), NCBI, 29 Apr 2020
https://www.ncbi.nlm.nih.gov/bioproject/?term=PRJEB37886
Dataset

1 Finished
1 Active

PACIFIC-19: Portsmouth Academic Consortium For Investigating COVID-19
Briggs, J., Prytherch, D., Kostakis, I., Robson, S., Price, C., Scott, P. & Kovacs, C.
30/03/20 → …
Project: Research
STOP COVID-19: Sequencing and Tracking Of Phylogeny in COVID-19
Robson, S., Scarlett, G., Bourgeois, Y., Beckett, A., Loveson, K., Glaysher, S., Chauhan, A., Goudarzi, S., Cook, K., Fearn, C., Paul, H. & Dent, H.
Public Health England, COG-UK
1/04/20 → 31/03/23
Project: Research

Cite this

@article{1690f37b691b40859d039541de74efd2,

title = "The SARS-CoV-2 B.1.1.7 variant and increased clinical severity—the jury is out",

author = "{COG-UK Consortium} and {PACIFIC-19 Consortium} and Benjamin Giles and Paul Meredith and Samuel Robson and Gary Smith and Anoop Chauhan",

note = "Funding Information: AC reports grants from NIHR, Asthma UK, Boehringer-Ingelheim Charity; consulting fees and honoraria from Sanofi; and support for meeting attendance from GSK. All other authors declare no competing interests.",

year = "2021",

month = sep,

doi = "10.1016/S1473-3099(21)00356-X",

language = "English",

volume = "21",

pages = "1213--1214",

journal = "Lancet Infectious Diseases",

issn = "1473-3099",

publisher = "Lancet Publishing Group",

number = "9",

}

TY - JOUR

T1 - The SARS-CoV-2 B.1.1.7 variant and increased clinical severity—the jury is out

AU - COG-UK Consortium

AU - PACIFIC-19 Consortium

AU - Giles, Benjamin

AU - Meredith, Paul

AU - Robson, Samuel

AU - Smith, Gary

AU - Chauhan, Anoop

N1 - Funding Information: AC reports grants from NIHR, Asthma UK, Boehringer-Ingelheim Charity; consulting fees and honoraria from Sanofi; and support for meeting attendance from GSK. All other authors declare no competing interests.

PY - 2021/9

Y1 - 2021/9

UR - http://www.scopus.com/inward/record.url?scp=85113383867&partnerID=8YFLogxK

U2 - 10.1016/S1473-3099(21)00356-X

DO - 10.1016/S1473-3099(21)00356-X

M3 - Comment/debate

C2 - 34197767

AN - SCOPUS:85113383867

SN - 1473-3099

VL - 21

SP - 1213

EP - 1214

JO - Lancet Infectious Diseases

JF - Lancet Infectious Diseases

IS - 9

ER -

The SARS-CoV-2 B.1.1.7 variant and increased clinical severity—the jury is out

UN SDGs

Access to Document

Datasets

Dataset: GISAID EpiCov SARS-CoV-2 Whole Genome Sequencing Database

COVID-19 Genomics UK (COG-UK) consortium

Projects

PACIFIC-19: Portsmouth Academic Consortium For Investigating COVID-19

STOP COVID-19: Sequencing and Tracking Of Phylogeny in COVID-19

Cite this